#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer

#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer

#ESMO21 Expert Video Report on immunotherapy in gastro-oesophageal cancerПодробнее

#ESMO21 Expert Video Report on immunotherapy in gastro-oesophageal cancer

Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancerПодробнее

Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancer

Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancerПодробнее

Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancer

ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancerПодробнее

ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer

#ESMO21 Expert Video Report on HER2-positive early breast cancerПодробнее

#ESMO21 Expert Video Report on HER2-positive early breast cancer

Breast cancer research at ESMO 2021Подробнее

Breast cancer research at ESMO 2021

#ESMO21 Expert Video Report on targeting in HER2-positive metastatic breast and lung cancersПодробнее

#ESMO21 Expert Video Report on targeting in HER2-positive metastatic breast and lung cancers

#ESMO21 Expert Video Report on Prostate cancerПодробнее

#ESMO21 Expert Video Report on Prostate cancer

HER2-positive breast cancer explanation videoПодробнее

HER2-positive breast cancer explanation video

HER2 Positive Breast Cancer: Everything You Must KnowПодробнее

HER2 Positive Breast Cancer: Everything You Must Know

Get ALL the info you need about HER2 +ve BREAST CANCER - HER2 +ve BREAST CANCER || Dr Liz O'RiordanПодробнее

Get ALL the info you need about HER2 +ve BREAST CANCER - HER2 +ve BREAST CANCER || Dr Liz O'Riordan

DESTINY Breast 03 from #ESMO21 presenter Dr. Erika HamiltonПодробнее

DESTINY Breast 03 from #ESMO21 presenter Dr. Erika Hamilton

Highlights in breast cancer from ESMO 2021Подробнее

Highlights in breast cancer from ESMO 2021

Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021Подробнее

Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021

PerELISA: overexpression of 13 genes associated with endocrine sensitivity in HR+/HER2+ BCПодробнее

PerELISA: overexpression of 13 genes associated with endocrine sensitivity in HR+/HER2+ BC

ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-WynneПодробнее

ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne

PD8 Spotlight Session 8 HER2 Positive Breast CancerПодробнее

PD8 Spotlight Session 8 HER2 Positive Breast Cancer